What Are Weight Loss Drugs Like Ozempic?

Last reviewed: June 27, 2026

Last updated: June 27, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Medications in the GLP-1 receptor agonist class have become a cornerstone of modern weight loss therapy, with clinical trials showing an average weight reduction of 15–22% over 68 weeks. These drugs work by mimicking a natural hormone that signals fullness to your brain and slows stomach emptying. PlexusDx brings this proven therapy to all 50 states through compounded formulations prepared by licensed 503A pharmacies.

How GLP-1 Weight Loss Medications Work

GLP-1 receptor agonists activate receptors in your brain, pancreas, and gut to reduce hunger signals and increase feelings of satisfaction after eating smaller portions. This mechanism also improves how your body regulates blood sugar levels, which can help prevent weight regain over time. The medication slows the rate at which food moves through your stomach, meaning you feel fuller for longer after meals.

Unlike older weight loss drugs that primarily stimulated metabolism or blocked fat absorption, GLP-1 therapies address the root biological pathways controlling appetite and satiety. Research shows this approach leads to more sustainable weight loss because it changes how your brain perceives hunger rather than forcing restriction through side effects. Studies consistently demonstrate that patients on GLP-1 therapy maintain weight loss better than those using diet and exercise alone.

Semaglutide vs. Other GLP-1 Medications

Semaglutide is a long-acting GLP-1 agonist designed to be dosed once weekly, making it more convenient than daily medications. It has the longest clinical track record, with over a decade of use in diabetes management before weight loss applications became standard. The medication reaches peak concentration about 1–3 days after injection, providing steady appetite suppression throughout the week.

Tirzepatide, by contrast, activates both GLP-1 and GIP receptors simultaneously, potentially offering greater weight loss in some patients—though individual response varies widely. PlexusDx offers both semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan and tirzepatide injections at $289/mo month-to-month, or from $249/mo on the 6-month plan, allowing personalization based on your unique peptide pathway response. Your dose may need to go up. Your price won't.

Clinical Evidence and Weight Loss Results

The STEP trials, which enrolled over 4,500 people with obesity, found that semaglutide 2.4 mg weekly produced an average weight loss of 14.9% of body weight over 68 weeks, compared to 2.4% with placebo. When combined with lifestyle modifications, patients achieved even greater results, with some studies showing weight reductions exceeding 20%. These outcomes held steady during extended follow-up periods, suggesting that the medication helps maintain rather than temporarily reduce weight.

Beyond weight loss, GLP-1 medications improve cardiovascular risk factors including blood pressure, triglycerides, and inflammation markers. Patients also report improvements in energy levels, mobility, and quality of life once they reach a stable dose. The consistency of these benefits across diverse populations supports their use as a foundational tool in precision weight management programs like those offered by PlexusDx.

Compounded Semaglutide: Access and Affordability

PlexusDx provides compounded semaglutide injections prepared by licensed 503A compounding pharmacies, ensuring quality and safety while bypassing high brand-name costs. The medication is available in all 50 states without requiring insurance, membership fees, or prior authorization—just a consultation with PlexusDx clinicians. Patients can use HSA or FSA accounts to cover the cost, adding another layer of affordability.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Common Side Effects and What to Expect

Nausea is the most frequently reported side effect, especially during dose escalation, occurring in 20–40% of patients in clinical trials. Other common effects include vomiting, constipation, and reduced appetite—which, while uncomfortable early on, often diminish as your body adapts over 2–4 weeks. Severe adverse events are rare; most patients find that side effects are manageable and outweighed by weight loss and improved metabolic health.

Starting with the lowest effective dose and titrating slowly minimizes nausea risk. PlexusDx clinicians work with you during dose adjustment phases to manage symptoms through dietary modifications, hydration, and anti-nausea strategies. If one GLP-1 formulation causes intolerable side effects, switching to oral semaglutide, tirzepatide, or the microdose GLP-1 protocol (starting at $129/month) provides alternatives that may be better tolerated while preserving therapeutic benefit.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Is compounded semaglutide as safe as the brand-name version?

Yes. PlexusDx sources all compounded medications from licensed 503A compounding pharmacies, which follow FDA manufacturing standards and quality controls. These facilities compound semaglutide to the same pharmaceutical grade as brand names, without the markup. Third-party testing and pharmacist oversight ensure purity and potency in every batch.

How much weight can I realistically lose with semaglutide?

No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Do I need insurance to use PlexusDx semaglutide?

No. PlexusDx serves all 50 states without requiring insurance, membership fees, or prior authorization. Compounded semaglutide is $189 monthly month-to-month, or from $149/mo on the 6-month plan and is HSA/FSA eligible, making it accessible to uninsured and self-pay patients. Most patients find the monthly cost far lower than brand-name alternatives.

What happens if I stop taking semaglutide?

Weight typically returns gradually over several months if diet and exercise do not change, though not always to baseline. This is why PlexusDx emphasizes lifestyle integration alongside medication—the drug is most effective as part of a sustained behavior change program. Some patients maintain weight loss long-term even after stopping, while others restart therapy seasonally or as needed.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Weight Loss Drugs Like Ozempic
• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Ozempic Weight Loss Before And After Pictures

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.